Abstract
BackgroundDifferent studies suggest that Rituximab (RTX) may be effective in lupus nephritis treatment. Nevertheless, systemic lupus erythematosus (SLE) is a heterogeneous disease with non-renal manifestations in which RTX has being...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
